Inhibition of HDAC1 and DNMT1 Modulate RGS10 Expression and Decrease Ovarian Cancer Chemoresistance
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of HDAC1 and DNMT1 Modulate RGS10 Expression and Decrease Ovarian Cancer Chemoresistance
Authors
Keywords
Ovarian cancer, Small interfering RNAs, DNA methylation, Histones, Apoptosis, Chromatin immunoprecipitation, Polymerase chain reaction, Epigenetics
Journal
PLoS One
Volume 9, Issue 1, Pages e87455
Publisher
Public Library of Science (PLoS)
Online
2014-01-28
DOI
10.1371/journal.pone.0087455
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of upregulated phosphoinositide 3-kinase γ as a target to suppress breast cancer cell migration and invasion
- (2013) Yan Xie et al. BIOCHEMICAL PHARMACOLOGY
- Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer - overexpression of HDAC2 and HDAC3 is associated with clinicopathological indicators of disease progression
- (2013) Berit Maria Müller et al. BMC CANCER
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The role of LPA and YAP signaling in long-term migration of human ovarian cancer cells
- (2013) Hui Cai et al. Cell Communication and Signaling
- Recent Trends and Future Prospects in Computational GPCR Drug Discovery: From Virtual Screening to Polypharmacology
- (2013) Antonio Carrieri et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- RGS17: an emerging therapeutic target for lung and prostate cancers
- (2013) Christopher R Bodle et al. Future Medicinal Chemistry
- Transcriptional Suppression, DNA Methylation, and Histone Deacetylation of the Regulator of G-Protein Signaling 10 (RGS10) Gene in Ovarian Cancer Cells
- (2013) Mourad W. Ali et al. PLoS One
- RGS10 exerts a neuroprotective role through the PKA/c-AMP response-element (CREB) pathway in dopaminergic neuron-like cells
- (2012) Jae-Kyung Lee et al. JOURNAL OF NEUROCHEMISTRY
- Histone deacetylases and cancer
- (2012) Bruna Barneda-Zahonero et al. Molecular Oncology
- Candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer identified by methylome and expression profiling
- (2012) C Zeller et al. ONCOGENE
- Brain RGS4 and RGS10 protein expression in schizophrenia and depression. Effect of drug treatment
- (2012) G. Rivero et al. PSYCHOPHARMACOLOGY
- HDAC4-Regulated STAT1 Activation Mediates Platinum Resistance in Ovarian Cancer
- (2011) E. A. Stronach et al. CANCER RESEARCH
- RGS10 Restricts Upregulation by Chemokines of T Cell Adhesion Mediated by 4 1 and L 2 Integrins
- (2011) D. Garcia-Bernal et al. JOURNAL OF IMMUNOLOGY
- Thailandepsins: Bacterial Products with Potent Histone Deacetylase Inhibitory Activities and Broad-Spectrum Antiproliferative Activities
- (2011) Cheng Wang et al. JOURNAL OF NATURAL PRODUCTS
- Recurrent ovarian cancer: Treatment with pegylated liposomal doxorubicin; a Westmead Cancer Care Centre experience
- (2010) Rachel F DEAR et al. Asia-Pacific Journal of Clinical Oncology
- A phase II study of two topotecan regimens evaluated in recurrent platinum-sensitive ovarian, fallopian tube or primary peritoneal cancer: A Gynecologic Oncology Group Study (GOG 146Q)
- (2010) Thomas J. Herzog et al. GYNECOLOGIC ONCOLOGY
- Cellular Histone Modification Patterns Predict Prognosis and Treatment Response in Resectable Pancreatic Adenocarcinoma: Results From RTOG 9704
- (2010) Ananya Manuyakorn et al. JOURNAL OF CLINICAL ONCOLOGY
- Ovarian cancer immunotherapy: opportunities, progresses and challenges
- (2010) Bei Liu et al. Journal of Hematology & Oncology
- Regulators of G-Protein signaling RGS10 and RGS17 regulate chemoresistance in ovarian cancer cells
- (2010) Shelley B Hooks et al. Molecular Cancer
- Histone Deacetylase Inhibitors: Recent Insights from Basic to Clinical Knowledge & Patenting of Anti-Cancer Actions
- (2010) Vincenzo Carafa et al. Recent Patents on Anti-Cancer Drug Discovery
- Global Levels of Histone Modifications Predict Prognosis in Different Cancers
- (2009) David B. Seligson et al. AMERICAN JOURNAL OF PATHOLOGY
- Regulator of G-protein signaling (RGS) proteins in cancer biology
- (2009) Jillian H. Hurst et al. BIOCHEMICAL PHARMACOLOGY
- DNMT1 and DNMT3B Modulate Distinct Polycomb-Mediated Histone Modifications in Colon Cancer
- (2009) B. Jin et al. CANCER RESEARCH
- Breast Cancer Migration and Invasion Depend on Proteasome Degradation of Regulator of G-Protein Signaling 4
- (2009) Y. Xie et al. CANCER RESEARCH
- RGS16 Inhibits Breast Cancer Cell Growth by Mitigating Phosphatidylinositol 3-Kinase Signaling
- (2009) Genqing Liang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Lysophosphatidic Acid Stimulates Cell Growth by Different Mechanisms in SKOV-3 and Caov-3 Ovarian Cancer Cells: Distinct Roles for Gi- and Rho-Dependent Pathways
- (2009) Jillian H. Hurst et al. PHARMACOLOGY
- HDAC family: What are the cancer relevant targets?
- (2008) Olaf Witt et al. CANCER LETTERS
- PCR differential display-based identification of regulator of G protein signaling 10 as the target gene in human colon cancer cells induced by black tea polyphenol theaflavin monogallate
- (2008) Jiebo Lu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Inhibition of Histone Deacetylases Promotes Ubiquitin-Dependent Proteasomal Degradation of DNA Methyltransferase 1 in Human Breast Cancer Cells
- (2008) Q. Zhou et al. MOLECULAR CANCER RESEARCH
- Epigenetic interplay between histone modifications and DNA methylation in gene silencing
- (2008) T VAISSIERE et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started